The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company's Emphysema Treatment Global Market Report 2023 identifies rise in the prevalence of chronic obstructive pulmonary disease (COPD) cases as the major driver for the Emphysema Treatment market's growth in the forecast period. Chronic obstructive pulmonary disease (COPD) is a set of disorders that cause airflow obstruction and breathing difficulties, including emphysema and chronic bronchitis. Emphysema therapies are essential in reducing the advancement of Chronic Obstructive Pulmonary Disease (COPD) as they focus on treating symptoms, restoring lung function, and delaying disease progression.
The global emphysema treatment market size is expected to grow from $4.65 billion in 2022 to $4.96 billion in 2023 at a compound annual growth rate (CAGR) of 6.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global emphysema treatment market size is expected to reach $6.34 billion in 2027 at a CAGR of 6.3%.
Download Free Sample Of Emphysema Treatment Market Report - www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp
Major competitors in the Emphysema Treatment market are AstraZeneca Plc., Teva Pharmaceuticals Industries Ltd., Novartis AG, GlaxoSmithKline Plc., Hikma Pharmaceuticals Plc.
A key trend in the Emphysema Treatment market includes product innovations. Major companies operating in the emphysema treatment market are focused on developing innovative products to strengthen their position in the market. For instance, in July 2020, AstraZeneca plc, a UK-based pharmaceutical and biotechnology company, received approval in the United States for its product Breztri Aerosphere for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). The FDA granted approval based on positive results from the Phase III ETHOS trial, in which Breztri Aerosphere, a triple-combination therapy, showed a statistically significant reduction in the rate of moderate or severe exacerbations when compared to dual-combination therapies, Bevespi Aerosphere and PT009.
Read More On The Global Emphysema Treatment Market Report Here:
The Emphysema Treatment market is segmented -
• By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
• By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
• By End-User: Clinics, Surgical Centre, Other End-Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Emphysema Treatment market.
The Business Research Company's "Global Emphysema Treatment Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Emphysema Treatment Market Report Here:
The Table Of Content For The Emphysema Treatment Market Include:
1. Executive Summary
2. Emphysema Treatment Market Characteristics
3. Emphysema Treatment Market Trends And Strategies
4. Emphysema Treatment Market - Macro Economic Scenario
5. Emphysema Treatment Market Size And Growth
26. Africa Emphysema Treatment Market
27. Emphysema Treatment Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Emphysema Treatment Market
29. Emphysema Treatment Market Future Outlook and Potential Analysis
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
Healthcare Blog: healthcareresearchreports.com/
Global Market Model: www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.